Front Range Pharmaceuticals

CompanyUnited States

Front Range Pharmaceuticals develops one asset, in phase 2 (FRP-003 in long COVID). Mostly small molecule; based in the United States.

1
Asset
Furthest stage
Phase 2
0
Trials
0
Signals

Pipeline

1
  • FRP-003

    Phase 2, Small molecule, long COVID

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies4

Intelligence